Novel approaches and mechanisms of immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-03-01 / Discov Med 2014 Mar;17(93):145-54Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-02-18 / J Immunother Cancer 2014;2:4Fighting fire with fire: the revival of thermotherapy for gliomas
/in Glioblastoma, Hyperthermia, International Publications /von 2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-74Myeloid-derived suppressor cells in glioma
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-11-12 / Expert Rev Neurother 2013 Dec;13(12):1395-406Dendritic cell vaccine for recurrent high-grade gliomas in pediatric and adult subjects: clinical trial protocol
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-11-01 / Neurosurgery 2013 Nov;73(5):863-7Dendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trials
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-10-21 / Neurol. Med. Chir. (Tokyo) 2013;53(11):741-54Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1043-6Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?
/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2013-07-02 / Cancer Immunol. Immunother. 2013 Sep;62(9):1499-509
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution